What is the official website of Sandoz Italia ?

The official website of Sandoz Italia is https://www.sandoz.it/.

What is Sandoz Italia's cybersecurity risk score?

Sandoz Italia has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz Italia experienced?

According to Rankiteo, Sandoz Italia currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz Italia been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz Italia has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz Italia have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz Italia is not certified under SOC 2 Type 1.

Does Sandoz Italia have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz Italia does not hold a SOC 2 Type 2 certification.

Does Sandoz Italia comply with GDPR ?

According to Rankiteo, Sandoz Italia is not listed as GDPR compliant.

Does Sandoz Italia have PCI DSS certification ?

According to Rankiteo, Sandoz Italia does not currently maintain PCI DSS compliance.

Does Sandoz Italia comply with HIPAA ?

According to Rankiteo, Sandoz Italia is not compliant with HIPAA regulations.

Does Sandoz Italia have ISO 27001 certification ?

According to Rankiteo,Sandoz Italia is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz Italia operate in ?

Sandoz Italia operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz Italia have ?

Sandoz Italia employs approximately 206 people worldwide.

Does Sandoz Italia own any subsidiaries ?

Sandoz Italia presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz Italia have ?

Sandoz Italia's official LinkedIn profile has approximately 34,636 followers.

What is the NAICS classification code for Sandoz Italia ?

Sandoz Italia is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz Italia have a Crunchbase profile ?

No, Sandoz Italia does not have a profile on Crunchbase.

Does Sandoz Italia have a LinkedIn profile ?

Yes, Sandoz Italia maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandoz-italia.

How many cybersecurity incidents has Sandoz Italia experienced ?

As of July 30, 2026, Rankiteo reports that Sandoz Italia has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz Italia have ?

Sandoz Italia has an estimated 5,712 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sandoz Italia

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Sandoz Italia Vendor Cyber Rating & Cyber Score

sandoz.it

Add Your Compliance Badge

Sandoz Italia è un'affiliata di Sandoz Global, leader mondiale nei farmaci generici e biosimilari. Il nostro scopo è favorire l'accesso ai farmaci per i pazienti di tutto il mondo. La nostra missione è promuovere l'innovazione nel settore sanitario liberando risorse in modo sostenibile e responsabile, continuando al tempo stesso a rispondere alle sfide globali per la salute, come la resistenza agli antimicrobici. I trattamenti sviluppati da Sandoz servono circa 500 milioni di persone ogni anno. Abbiamo due principali attività globali: i generici, divisi tra generici standard (principalmente solidi orali) e generici complessi (compresi iniettabili, respiratori e altri) i biosimilari, dove siamo i pionieri globali, con otto farmaci

Sandoz Italia A.I CyberSecurity Scoring

Scoring History

Sandoz Italia

Sandoz Italia CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Sandoz Italia Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sandoz Italia

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Italia in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz Italia in 2026.

Incident Types Sandoz Italia vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Italia in 2026.

Incident History - Sandoz Italia (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz Italia Subsidiaries

Sandoz Italia

Pharmaceutical Manufacturing

Website: https://www.sandoz.it/

Company Size: 201-500 employees

SandozPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Lek PharmaceuticalsPharmaceutical Manufacturing

Sandoz EgyptPharmaceutical Manufacturing

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz SrbijaPharmaceutical Manufacturing

Sandoz ÖsterreichPharmaceutical Manufacturing

Sandoz CanadaPharmaceutical Manufacturing

Sandoz HrvatskaPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz in DeutschlandPharmaceutical Manufacturing

Sandoz NederlandPharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Sandoz RomaniaPharmaceutical Manufacturing

Sandoz India Pvt LtdPharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Sandoz BelgiumPharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Life at SandozArzneimittelherstellung

Sandoz IberiaPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Loading…

Sandoz Italia Similar Companies

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Loading…

NEWS

Sandoz Italia CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-67595

SUMMARY

VaahCMS versions 2.0.0 through 2.3.4 contain a malicious obfuscated JavaScript payload embedded in the Blade template responsible for rendering security OTP emails, allowing remote attackers to execute unauthorized code in any browser that renders the affected email template with JavaScript enabled. The payload establishes a WebSocket connection to a hardcoded command-and-control endpoint, installs a password-field keylogger using MutationObserver to capture dynamically added inputs, scrapes WhatsApp Web DOM content, and accepts remote commands to redirect or overwrite the rendered page.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.2

REFERENCES

CVE-2026-15157

SUMMARY

undici does not validate the type property of a duck-typed blob-like request body before using it as the Content-Type header on the HTTP/1.1 dispatcher. In undici before 6.28.0, from 7.0.0 up to before 7.29.0, and from 8.0.0 up to before 8.9.0, an application that passes a hand-rolled blob-like body (via request, stream, pipeline, or dispatch) whose type is derived from untrusted input allows an attacker to inject CRLF sequences and append arbitrary HTTP headers, potentially smuggling a second request past the upstream. Native Blob objects are safe because their constructor strips CRLF from the type, and fetch is unaffected because it validates headers, but ecosystem libraries that build duck-typed blob shapes from user input can reach the vulnerable path. This is the same defect class as CVE-2022-35948 and CVE-2026-1527, on a header sink that the earlier fixes did not cover. The issue is fixed in undici 6.28.0, 7.29.0, and 8.9.0.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: 4.2)

cvss3

Base Score: 4.2

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

1.6

REFERENCES

CVE-2026-14643

SUMMARY

undici's cache interceptor mishandles optional whitespace placed around the equals sign of a qualified no-cache or private Cache-Control directive. In undici from 7.0.0 up to before 7.29.0 and from 8.0.0 up to before 8.9.0, the parser either drops the directive or stores a field name with literal quote characters, so the cache decision fails to recognize the qualification and the response is stored. In shared-cache mode, this lets a response containing one user's authenticated data be served from cache to a later caller, including an unauthenticated one, when both requests resolve to the same cache key. It affects applications that enable the cache interceptor in shared mode, forward Authorization headers upstream, and receive cacheable responses with qualified directives padded with whitespace around the equals sign. This is the whitespace-around-equals variant that the fix for CVE-2026-9678 did not normalize, and it is fixed in undici 7.29.0 and 8.9.0.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2025-69949

SUMMARY

kishan0725 Hospital Management System 4.0 is vulnerable to SQL Injection in check_availability.php via the parameters emailid and email.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2025-69945

SUMMARY

kishan0725 Hospital Management System 4.0 is vulnerable to SQL Injection in /doctor/edit-patient.php?editid=1.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://github.com/um-dsp/TaintRadar/blob/main/sql_injection_cves/hospitalmanagementsystemproject/20250811-hospital-management-system-edit-patient.php-editid-sqli/20250811-hospital-management-system-edit-patient.php-editid-sqli.md

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…